AzTrials
AzTrials

HIV-1-infectionETENCT06890988

Ending the Epidemic Interventions in the Dental Setting - UH3

A study testing Care Navigator and Multicomponent HIV Service Package in people with HIV-1-infection, run by Columbia University at 3 sites in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is to use information technology (IT) to support the efficient delivery of HIV prevention and care best practices in the dental care setting. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
HIV-1-infection
What is being tested?
Care Navigator and Multicomponent HIV Service Package
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
128 participants
Where
3 sitesUnited States
Study dates
31 Mar 2025to 1 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Member of the Dental Team (Provider, Hygienist, Dental Assistant, Care Navigator) at one of the randomized sites with direct patient contact
  • Able to provide written informed consent.

Who cannot join

  • Inability to provide written informed consent.

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Michael Yin, MD, MS contact

212-305-7185

mty4@cumc.columbia.edu

Nadia Nguyen, PhD contact

nn2442@cumc.columbia.edu

United States3 sites, 3 recruiting
  • Columbia University Irving Medical Center / NewYork-Presbyterian Hospital

    New York, New York, 10032

    Michael Yin, MD, MS, 212-305-7185, mty4@cumc.columbia.edu

    Nadia Nguyen, PhD, 212-304-6212, nn2442@cumc.columbia.edu

    Recruiting
  • Weill Cornell Medical Center / NewYork-Presbyterian Hospital

    New York, New York, 10065

    Ariel Blanchard, DMD, (212) 746-5175, aab9028@med.cornell.edu

    Nadia Nguyen, PhD, 212-304-6212, nn2442@cumc.columbia.edu

    Not yet recruiting
  • NYP-Queens

    Queens, New York, 11365

    Marsha Rubin, DDS, Mer2009@med.cornell.edu

    Not yet recruiting

Other trials in United States

About this study

Official title: Effectiveness of Comprehensive Ending the Epidemic (ETE) Interventions in the Dental Setting

The purpose of this study is to use information technology (IT) to support the efficient delivery of HIV prevention and care best practices in the dental care setting.

Read the detailed description

Routine preventative HIV screening in all health care settings is considered a best practice by the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (DHHS) Ending the Epidemic (ETE) Initiative, the New York State Blueprint to End the AIDS Epidemic. Despite this, many patients are not screened for HIV during routine care, including in dental care settings, resulting in missed opportunities for identifying undiagnosed HIV infections and providing education for pre-exposure prophylaxis (PrEP). This study will use information technology to support the delivery of HIV prevention and care best practices in the dental care setting. Dental residents will receive a Best Practice (BPA) alert whenever they have a patient who should be offered HIV screening. This BPA is linked to an order set to simplify ordering HIV tests and reporting results.

A critical knowledge gap for implementing these ETE activities in the dental setting is whether comprehensive ETE efforts could be integrated into existing dental teams consisting of practitioners, dental assistants and hygienists or require augmentation by a dedicated care navigator. To evaluate these two models, the investigators will conduct a crossover clinical trial in 3 urban general dentistry programs (NYP-Columbia, NYP-Cornell, NYP-Queens) randomized to one of 2 arms: (AB) Standard Dental Care Team model followed by crossover to an Enhanced Dental Care Team model with a Care Navigator, or (BA) Enhanced Dental Care Team model with a Care Navigator followed by crossover to a Standard Dental Care Team model.

Conditions
HIV-1-infection
Being tested
Care Navigator, Multicomponent HIV Service Package
Keywords
clinical decision support, acceptability, feasibility, implementation science, HIV testing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Care NavigatorOther

    The Care Navigator will be added to the dental team as an added resource to:

    1. Champion the use of the multicomponent HIV intervention in the dental clinic among clinic administrators, residents, dental hygienists, dental assistants, and other dental team staff.
    2. Provide technical assistance
    3. Provide logistical assistance ; and
    4. Support dental team in educating patients about HIV prevention and treatment options
  • Multicomponent HIV Service PackageOther

    Multicomponent HIV Service Package consisting of:

    1. Clinical Decision Support (CDS) within electronic medical record (EMR) system to help providers identify patients who would benefit from HIV screening or re-engagement in HIV care.
    2. Point-of-care HIV testing in the dental clinic.
    3. Patient and provider-facing educational materials to support providers in discussing HIV prevention options (for patients who test HIV negative) and treatment (for patients who test HIV positive or are out of HIV care) options.
Study groups in NCT06890988
Study groupRoleWhat they receive
Standard Dental Care Team modelPlacebo comparatorMulticomponent HIV Service Package delivered without a Care Navigator
Receives: Other: Multicomponent HIV Service Package
Enhanced Dental Care Team model with a Care NavigatorExperimentalMulticomponent HIV Service Package delivered with a Care Navigator
Receives: Other: Care Navigator; Other: Multicomponent HIV Service Package

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of patients that complete point of care HIV testing out of patient encounters receiving clinical decision support (CDS) prompts for HIV testing

    Proportion of patients receiving clinical decision support (CDS) prompts for HIV testing that complete point of care HIV testing over the intervention period under the Enhanced versus Standard Dental Care Models.

    Measured: 10 months after start of each arm

Secondary outcomes (5)
  1. Provider acceptability of multicomponent HIV service package in dental clinics

    Provider acceptability of multicomponent HIV service package in dental clinics under the Enhanced versus Standard Dental Care Models. Acceptability will be assessed using the validated Acceptability of Intervention Measure (AIM). AIM is a 4-item scale where respondents rate each item using a 5-point ordinal scale that ranges from "completely disagree=1" to "completely agree=5". The AIM is scored by averaging responses across the 4 items. A higher average score indicates greater acceptability, which is a better outcome.

    Measured: 5-10 months after start of each arm

  2. Provider feasibility of multicomponent HIV service package in dental clinics

    Provider feasibility of multicomponent HIV service package in dental clinics under the Enhanced versus Standard Dental Care Models. Feasibility will be assessed using the validated Feasibility of Intervention Measure (FIM). FIM is a 4-item scale where respondents rate each item using a 5-point ordinal scale that ranges from "completely disagree=1" to "completely agree=5". The FIM is scored by averaging responses across the 4 items. A higher average score indicates greater acceptability, which is a better outcome.

    Measured: 5-10 months after start of each arm

  3. Proportion of patients receiving CDS prompt for HIV testing that complete subsequent HIV testing outside of the dental clinic

    Proportion of patients receiving CDS prompt for HIV testing that complete subsequent HIV testing outside of the dental clinic under the Enhanced versus Standard Dental Care Models.

    Measured: Within 12 months following dental visit

  4. Proportion of patients receiving CDS prompt for HIV testing with subsequent appointment at an HIV prevention clinic

    Proportion of patients receiving CDS prompt for HIV testing with subsequent appointment at an HIV prevention clinic under the Enhanced versus Standard Dental Care Models.

    Measured: Within 12 months following dental visit

  5. Proportion of patients receiving CDS prompt for HIV testing subsequently prescribed pre-exposure prophylaxis (PrEP) medication

    Proportion of patients receiving CDS prompt for HIV testing subsequently prescribed pre-exposure prophylaxis (PrEP) medication under the Enhanced versus Standard Dental Care Models.

    Measured: Within 12 months following dental visit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2025
  2. Study start31 Mar 2025
  3. Primary completion1 Sep 2027 (estimated)
  4. Study completion1 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Crossover
Model description
Sites will be randomized to one of 2 arms: (AB) Standard Dental Care Team model followed by crossover to an Enhanced Dental Care Team model with a Care Navigator, or (BA) Enhanced Dental Care Team model with a Care Navigator followed by crossover to a Standard Dental Care Team model.
Masking
None (open label)
Enrolment
128 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06890988
Sponsor's protocol ID
AAAT8854 - UH3
Other IDs
4UH3DE031258
Acronym
ETE
Status last verified
Oct 2026
First submitted
14 Mar 2025
Last updated
7 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified participant data may be shared with other researchers within Columbia University at the discretion of the Principal Investigator, and only when the Institutional Review Board (IRB) approval has been granted to allow for the sharing of such data.

Questions about this trial

What is this clinical trial studying?

A study testing Care Navigator and Multicomponent HIV Service Package in people with HIV-1-infection, run by Columbia University at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 7 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Michael Yin, MD, MS (212-305-7185, mty4@cumc.columbia.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of patients that complete point of care HIV testing out of patient encounters receiving clinical decision support (CDS) prompts for HIV testing (time frame: 10 months after start of each arm). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Oct 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in